Home Cart 0 Sign in  

[ CAS No. 575-44-0 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 575-44-0
Chemical Structure| 575-44-0
Structure of 575-44-0 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 575-44-0 ]

Related Doc. of [ 575-44-0 ]

Alternatived Products of [ 575-44-0 ]

Product Details of [ 575-44-0 ]

CAS No. :575-44-0 MDL No. :MFCD00003981
Formula : C10H8O2 Boiling Point : -
Linear Structure Formula :- InChI Key :FZZQNEVOYIYFPF-UHFFFAOYSA-N
M.W : 160.17 Pubchem ID :68463
Synonyms :

Calculated chemistry of [ 575-44-0 ]

Physicochemical Properties

Num. heavy atoms : 12
Num. arom. heavy atoms : 10
Fraction Csp3 : 0.0
Num. rotatable bonds : 0
Num. H-bond acceptors : 2.0
Num. H-bond donors : 2.0
Molar Refractivity : 47.99
TPSA : 40.46 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.9 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.36
Log Po/w (XLOGP3) : 1.94
Log Po/w (WLOGP) : 2.25
Log Po/w (MLOGP) : 1.88
Log Po/w (SILICOS-IT) : 2.01
Consensus Log Po/w : 1.89

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.67
Solubility : 0.341 mg/ml ; 0.00213 mol/l
Class : Soluble
Log S (Ali) : -2.41
Solubility : 0.617 mg/ml ; 0.00385 mol/l
Class : Soluble
Log S (SILICOS-IT) : -2.91
Solubility : 0.197 mg/ml ; 0.00123 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.0

Safety of [ 575-44-0 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 575-44-0 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 575-44-0 ]
  • Downstream synthetic route of [ 575-44-0 ]

[ 575-44-0 ] Synthesis Path-Upstream   1~17

  • 1
  • [ 575-44-0 ]
  • [ 32940-15-1 ]
Reference: [1] Synlett, 2005, # 13, p. 2043 - 2046
[2] Australian Journal of Chemistry, 1998, vol. 51, # 5, p. 389 - 396
[3] Journal of Medicinal Chemistry, 1993, vol. 36, # 20, p. 2891 - 2898
[4] Journal of the Chemical Society, 1949, p. 1855,1862[5] Journal of the Chemical Society, 1946, p. 676,679
[6] Journal of Medicinal Chemistry, 2012, vol. 55, # 12, p. 5720 - 5733
  • 2
  • [ 59335-81-8 ]
  • [ 575-44-0 ]
Reference: [1] Tetrahedron, 2000, vol. 56, # 2, p. 317 - 321
  • 3
  • [ 119-79-9 ]
  • [ 575-44-0 ]
Reference: [1] Helvetica Chimica Acta, 1920, vol. 3, p. 321
  • 4
  • [ 135-19-3 ]
  • [ 581-43-1 ]
  • [ 575-38-2 ]
  • [ 575-44-0 ]
  • [ 582-17-2 ]
Reference: [1] Tetrahedron Letters, 1983, vol. 24, # 30, p. 3099 - 3102
[2] Tetrahedron Letters, 1983, vol. 24, # 30, p. 3099 - 3102
  • 5
  • [ 117-62-4 ]
  • [ 575-44-0 ]
Reference: [1] Journal fuer Praktische Chemie (Leipzig), 1921, vol. <2> 103, p. 135,136, 151, 153
[2] Journal fuer Praktische Chemie (Leipzig), 1921, vol. <2> 103, p. 135,136, 151, 153
  • 6
  • [ 81-16-3 ]
  • [ 575-44-0 ]
Reference: [1] Journal fuer Praktische Chemie (Leipzig), 1921, vol. <2> 103, p. 135,136, 151, 153
[2] Journal fuer Praktische Chemie (Leipzig), 1921, vol. <2> 103, p. 135,136, 151, 153
  • 7
  • [ 871887-69-3 ]
  • [ 575-44-0 ]
Reference: [1] Journal fuer Praktische Chemie (Leipzig), 1921, vol. <2> 103, p. 135,136, 151, 153
  • 8
  • [ 86-97-5 ]
  • [ 575-44-0 ]
Reference: [1] Journal of the Chemical Society, 1955, p. 3348,3360
  • 9
  • [ 858464-85-4 ]
  • [ 575-44-0 ]
Reference: [1] Journal fuer Praktische Chemie (Leipzig), 1921, vol. <2> 103, p. 135,136, 151, 153
  • 10
  • [ 91-20-3 ]
  • [ 90-15-3 ]
  • [ 575-44-0 ]
  • [ 135-19-3 ]
Reference: [1] Journal of Organic Chemistry, 1991, vol. 56, # 21, p. 6148 - 6151
  • 11
  • [ 7664-93-9 ]
  • [ 861341-81-3 ]
  • [ 575-44-0 ]
  • [ 62-53-3 ]
Reference: [1] Journal fuer Praktische Chemie (Leipzig), 1921, vol. <2> 103, p. 272
  • 12
  • [ 871887-69-3 ]
  • [ 62-53-3 ]
  • [ 575-44-0 ]
  • [ 139263-46-0 ]
  • [ 858464-85-4 ]
  • [ 861341-81-3 ]
Reference: [1] Journal fuer Praktische Chemie (Leipzig), 1921, vol. <2> 103, p. 272
  • 13
  • [ 575-44-0 ]
  • [ 19125-84-9 ]
YieldReaction ConditionsOperation in experiment
74% With phosphorus tribromide In acetonitrile for 48 h; Example 20 : Preparation of compound 50; [235] <n="79"/>[236] 20-A. Preparation of compound 20a; [237] To 1,6-dihydroxynaphthalene (1.2g, 7.68 mmol), acetonitrile (50 mL), PBr (2.9 Ig,10.8 mmol) was added, and heated under stirring for 48 hours. The mixture was cooled to normal temperature and then was added methanol (100 mL) to precipitate a solid. After the solid was filtered, washed with methanol sufficiently and dried to prepare a compound 20a 1,6-dibromonaphthalene (1.6 g, 74percent). [M] = 286
Reference: [1] Patent: WO2007/86695, 2007, A1, . Location in patent: Page/Page column 76-77
[2] Bioorganic and Medicinal Chemistry Letters, 2008, vol. 18, # 1, p. 267 - 273
  • 14
  • [ 575-44-0 ]
  • [ 74-88-4 ]
  • [ 3900-49-0 ]
YieldReaction ConditionsOperation in experiment
90% With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 2 h; Into a round-bottom flask equipped with a stirring apparatus, 1.6 g (10.0 mmol) of 1,6-dihydroxynaphthalene (Compound 39: produced by Tokyo Chemical Industry Co., Ltd.), and 15 mL of N,N-dimethylformamide (DMF) were added for dissolution, and thrther 14.2 g (100.0 mmol) of methyl iodide (produced by Wako Pure Chemical Industries, Ltd.), and 13.8 g (100.0 mmol) of potassium carbonate (produced by Wako Pure Chemical Industries, Ltd.) were added, and the reaction was carried out at room temperature for 2 hours. Afier completion of the reaction, dichloromethane and water were added, and then an organic layer, obtained by solution separation, was washed with water, and the solvent was removed from the reaction solution by concentration under reduced pressure to obtain 1 .7 g (yield:90percent) of a colorless liquid methyl derivative (Compound40).
Reference: [1] Patent: US2017/342031, 2017, A1, . Location in patent: Paragraph 0643
  • 15
  • [ 575-44-0 ]
  • [ 77-78-1 ]
  • [ 3900-49-0 ]
Reference: [1] Organic Process Research and Development, 2009, vol. 13, # 3, p. 647 - 651
[2] Synlett, 2005, # 13, p. 2043 - 2046
[3] Journal of Medicinal Chemistry, 2009, vol. 52, # 18, p. 5590 - 5602
[4] Journal of the American Chemical Society, 2017, vol. 139, # 51, p. 18522 - 18535
[5] Journal of the Chemical Society, 1949, p. 1855,1862[6] Journal of the Chemical Society, 1946, p. 676,679
[7] Journal fuer Praktische Chemie (Leipzig), 1916, vol. &lt;2&gt; 94, p. 3
[8] Journal of Medicinal Chemistry, 1993, vol. 36, # 20, p. 2891 - 2898
[9] Journal of Organic Chemistry, 1986, vol. 51, # 26, p. 5252 - 5258
[10] Australian Journal of Chemistry, 1998, vol. 51, # 5, p. 389 - 396
[11] Journal of Medicinal Chemistry, 2007, vol. 50, # 22, p. 5293 - 5300
[12] Journal of Medicinal Chemistry, 2012, vol. 55, # 12, p. 5720 - 5733
  • 16
  • [ 67-56-1 ]
  • [ 575-44-0 ]
  • [ 3900-49-0 ]
  • [ 22604-07-5 ]
  • [ 150712-57-5 ]
Reference: [1] Australian Journal of Chemistry, 1993, vol. 46, # 5, p. 731 - 737
  • 17
  • [ 575-44-0 ]
  • [ 4018-91-1 ]
Reference: [1] Journal of Medicinal Chemistry, 1993, vol. 36, # 20, p. 2891 - 2898
Same Skeleton Products
Historical Records

Pharmaceutical Intermediates of
[ 575-44-0 ]

Rotigotine Intermediates

Chemical Structure| 32940-15-1

[ 32940-15-1 ]

5-Methoxy-2-tetralone

Chemical Structure| 20312-36-1

[ 20312-36-1 ]

L-3-Phenyllactic Acid

Chemical Structure| 40412-06-4

[ 40412-06-4 ]

2-(Thiophen-2-yl)ethyl 4-methylbenzenesulfonate

Chemical Structure| 17199-29-0

[ 17199-29-0 ]

(S)-2-Hydroxy-2-phenylacetic acid

Chemical Structure| 2032-33-9

[ 2032-33-9 ]

N-Benzylpropan-1-amine